This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. TACT has the following Specific Aims: To determine if chelation or high-dose supplements in patients with CAD improve event-free survival; To determine if chelation and high-dose supplements are safe in patients with CAD; To determine if chelation or high-dose supplements in patients with CAD improve quality of life; To determine if chelation or high-dose supplements in patients with CAD are cost effective.
Showing the most recent 10 out of 426 publications